Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

BACKGROUND: Standardized salvage treatment has not yet proved effective in glioblastoma multiforme (GBM) patients who receive prior standard radiotherapy plus concomitant and adjuvant temozolomide. METHODS: Patients with progressive GBM after radiotherapy plus concomitant and/or adjuvant temozolomid...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandes, Alba A., Tosoni, A., Franceschi, E., Blatt, V., Santoro, A., Faedi, M., Amistà, P., Gardiman, M., Labianca, R., Bianchini, C., Ermani, M., Reni, M.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717374/
https://www.ncbi.nlm.nih.gov/pubmed/19169684
http://dx.doi.org/10.1007/s00280-009-0926-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717374/
https://www.ncbi.nlm.nih.gov/pubmed/19169684
http://dx.doi.org/10.1007/s00280-009-0926-8

Ejemplares similares